CompletedN/ADMT
Prospective Stratification of Infectious Risks in Multiple Sclerosis
Sponsored by University Hospital, Basel, Switzerland
NCT ID
NCT04036097
Target Enrollment
298 participants
Start Date
2019-04-10
Est. Completion
2023-12-31
About This Study
This monocentric study is to identify factors that increase the susceptibility for infections and establish a questionnaire-based infection score that allows a prospective stratification for infectious risks in patients with multiple sclerosis (MS) (InRIMS-Study). The study will utilize a validated, MS-adapted questionnaire and infection diary from the Airway Infection Susceptibility (AWIS) study in a regularly followed, prospective cohort of MS patients. It is a nested project of the prospective observational Swiss MS Cohort (SMSC) and SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation) studies.
Conditions Studied
Interventions
- •MS-adapted AWIS questionnaire (MS-AWIS)
- •infection diary (MS-AWIS diary)
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Signed informed consent form (ICF) for the InRIMS-study and Swiss MS Cohort (SMSC) and/or Serially Unified Multicenter Multiple Sclerosis Investigation (SUMMIT) study Exclusion Criteria: * Not able to sufficiently understand the patient information and questionnaire (German language) * MS Patients with long-term antibiotic prophylaxis * MS Patients with known primary immunodeficiency, under chemotherapy due to any malignancy or HIV infection.
Study Locations (1)
University Hospital Basel, Department of Neurology
Basel, Switzerland